<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font22 { font-size : 22; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font22">and </span>
   <span class="font16">CAR-T </span>
   <span class="font15">for </span>
   <span class="font13">with </span>
   <span class="font12">cells </span>
   <span class="font12">The </span>
   <span class="font12">cell </span>
   <span class="font12">clinical </span>
   <span class="font12">are </span>
   <span class="font11">that </span>
   <span class="font11">():â€". </span>
   <span class="font11">patients </span>
   <span class="font11">unit </span>
   <span class="font11">{background </span>
   <span class="font11">requirements </span>
   <span class="font10">this </span>
   <span class="font10">(). </span>
   <span class="font10">This </span>
   <span class="font10">antigen </span>
   <span class="font10">solid </span>
   <span class="font10">therapy </span>
   <span class="font10">can </span>
   <span class="font10">margin </span>
   <span class="font10">specialist </span>
   <span class="font10">tumor </span>
   <span class="font10">have </span>
   <span class="font10">{border-style </span>
   <span class="font10">cancer </span>
   <span class="font10">product </span>
   <span class="font10">cells. </span>
   <span class="font10">px;} </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">activities </span>
   <span class="font10">has </span>
   <span class="font10">regulatory </span>
   <span class="font10">organizational </span>
   <span class="font10">quality </span>
   <span class="font10">chimeric </span>
   <span class="font10">different </span>
   <span class="font10">tissue </span>
   <span class="font10">been </span>
   <span class="font10">immune </span>
   <span class="font10">including </span>
   <span class="font10">receptor </span>
   <span class="font10">should </span>
   <span class="font10">B-cell </span>
   <span class="font10">Directive </span>
   <span class="font10">care </span>
   <span class="font10">from </span>
   <span class="font10">infusion </span>
   <span class="font10">management </span>
   <span class="font10">specific </span>
   <span class="font10">their </span>
   <span class="font10">Blood </span>
   <span class="font10">CAR </span>
   <span class="font10">Cancer </span>
   <span class="font10">Immunol </span>
   <span class="font10">Med </span>
   <span class="font10">after </span>
   <span class="font10">collection </span>
   <span class="font10">may </span>
   <span class="font10">will </span>
   <span class="font10">European </span>
   <span class="font10">GMP </span>
   <span class="font10">activity </span>
   <span class="font10">following </span>
   <span class="font10">not </span>
   <span class="font10">such </span>
   <span class="font10">target </span>
   <span class="font10">therapy. </span>
   <span class="font10">tumors </span>
   <span class="font10">unit, </span>
   <span class="font10">Cells </span>
   <span class="font10">Clin </span>
   <span class="font10">JACIE </span>
   <span class="font10">Oncol </span>
   <span class="font10">Unit </span>
   <span class="font10">dedicated </span>
   <span class="font10">evaluation </span>
   <span class="font10">high </span>
   <span class="font10">knowledge </span>
   <span class="font10">model </span>
   <span class="font10">role </span>
   <span class="font10">tissues </span>
   <span class="font10">ATMP </span>
   <span class="font10">CRS </span>
   <span class="font10">Cell </span>
   <span class="font10">also </span>
   <span class="font10">apheresis </span>
   <span class="font10">either </span>
   <span class="font10">guidelines </span>
   <span class="font10">medical </span>
   <span class="font10">process </span>
   <span class="font10">processing </span>
   <span class="font10">products </span>
   <span class="font10">safety </span>
   <span class="font10">single </span>
   <span class="font10">therapies </span>
   <span class="font10">these </span>
   <span class="font10">transplant </span>
   <span class="font10">treatment </span>
   <span class="font10">unit. </span>
   <span class="font10">which </span>
   <span class="font10">within </span>
   <span class="font10">(â€"). </span>
   <span class="font10">./s--- </span>
   <span class="font10">Marrow </span>
   <span class="font10">T-cell </span>
   <span class="font10">Ther </span>
   <span class="font10">acute </span>
   <span class="font10">between </span>
   <span class="font10">centers </span>
   <span class="font10">expertise </span>
   <span class="font10">human </span>
   <span class="font10">involved </span>
   <span class="font10">laboratory </span>
   <span class="font10">lymphoblastic </span>
   <span class="font10">malignancies </span>
   <span class="font10">manufacturing </span>
   <span class="font10">novel </span>
   <span class="font10">only </span>
   <span class="font10">px; </span>
   <span class="font10">requires </span>
   <span class="font10">responsibility </span>
   <span class="font10">through </span>
   <span class="font10">training </span>
   <span class="font10">{font-family </span>
   <span class="font10">//EC </span>
   <span class="font10">Commission </span>
   <span class="font10">Committee </span>
   <span class="font10">Mol </span>
   <span class="font10">Res </span>
   <span class="font10">These </span>
   <span class="font10">Transplant </span>
   <span class="font10">according </span>
   <span class="font10">administration </span>
   <span class="font10">all </span>
   <span class="font10">associated </span>
   <span class="font10">blood </span>
   <span class="font10">disease </span>
   <span class="font10">facilities, </span>
   <span class="font10">font-size </span>
   <span class="font10">important </span>
   <span class="font10">into </span>
   <span class="font10">lymphoma </span>
   <span class="font10">manipulation </span>
   <span class="font10">medicinal </span>
   <span class="font10">multi-disciplinary </span>
   <span class="font10">need </span>
   <span class="font10">order </span>
   <span class="font10">other </span>
   <span class="font10">personnel </span>
   <span class="font10">procedures </span>
   <span class="font10">release </span>
   <span class="font10">represents </span>
   <span class="font10">scientific </span>
   <span class="font10">several </span>
   <span class="font10">standard </span>
   <span class="font10">stem </span>
   <span class="font10">toxicities </span>
   <span class="font10">type </span>
   <span class="font10">under </span>
   <span class="font10">():. </span>
   <span class="font10">Accreditation </span>
   <span class="font10">Antigen </span>
   <span class="font10">Chimeric </span>
   <span class="font10">Engl </span>
   <span class="font10">Moreover, </span>
   <span class="font10">Program </span>
   <span class="font10">Sci </span>
   <span class="font10">anti-CD </span>
   <span class="font10">biological </span>
   <span class="font10">but </span>
   <span class="font10">charge </span>
   <span class="font10">complex </span>
   <span class="font10">coordination </span>
   <span class="font10">development </span>
   <span class="font10">double; </span>
   <span class="font10">efficacy </span>
   <span class="font10">facility </span>
   <span class="font10">factors </span>
   <span class="font10">final </span>
   <span class="font10">hematological </span>
   <span class="font10">ii) </span>
   <span class="font10">limited </span>
   <span class="font10">lymphocytes </span>
   <span class="font10">multiple </span>
   <span class="font10">organization </span>
   <span class="font10">processing, </span>
   <span class="font10">production </span>
   <span class="font10">referred </span>
   <span class="font10">related </span>
   <span class="font10">risk </span>
   <span class="font10">selection </span>
   <span class="font10">standards </span>
   <span class="font10">system </span>
   <span class="font10">therapeutic </span>
   <span class="font10">those </span>
   <span class="font10">trial </span>
   <span class="font10">tumors: </span>
   <span class="font10">two </span>
   <span class="font10">where </span>
   <span class="font10">while </span>
   <span class="font10">():e. </span>
   <span class="font10">./NEJMoa </span>
   <span class="font10">ATMPs </span>
   <span class="font10">According </span>
   <span class="font10">Article </span>
   <span class="font10">Collection </span>
   <span class="font10">However, </span>
   <span class="font10">Quality </span>
   <span class="font10">San </span>
   <span class="font10">Society </span>
   <span class="font10">Therapy </span>
   <span class="font10">adult </span>
   <span class="font10">adverse </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">both </span>
   <span class="font10">burden </span>
   <span class="font10">center. </span>
   <span class="font10">centers. </span>
   <span class="font10">complexity </span>
   <span class="font10">considered </span>
   <span class="font10">criteria </span>
   <span class="font10">donor </span>
   <span class="font10">drugs </span>
   <span class="font10">engineered </span>
   <span class="font10">establishment </span>
   <span class="font10">even </span>
   <span class="font10">framework </span>
   <span class="font10">immunotherapy. </span>
   <span class="font10">infusion. </span>
   <span class="font10">intensive </span>
   <span class="font10">large </span>
   <span class="font10">leukemia. </span>
   <span class="font10">low </span>
   <span class="font10">most </span>
   <span class="font10">one </span>
   <span class="font10">patients. </span>
   <span class="font10">pharmaceutical </span>
   <span class="font10">practice </span>
   <span class="font10">prognostic </span>
   <span class="font10">provide </span>
   <span class="font10">rapid </span>
   <span class="font10">regulated </span>
   <span class="font10">represented </span>
   <span class="font10">required </span>
   <span class="font10">responsible </span>
   <span class="font10">shall </span>
   <span class="font10">since </span>
   <span class="font10">solid; </span>
   <span class="font10">studies </span>
   <span class="font10">syndrome </span>
   <span class="font10">they </span>
   <span class="font10">toxicity </span>
   <span class="font10">trials </span>
   <span class="font10">tumors. </span>
   <span class="font10">units </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">:â€". </span>
   <span class="font10">Advanced </span>
   <span class="font10">BMT </span>
   <span class="font10">Clinical </span>
   <span class="font10">Curr </span>
   <span class="font10">FACT-JACIE </span>
   <span class="font10">Fondazione </span>
   <span class="font10">IRCCS </span>
   <span class="font10">Policlinico </span>
   <span class="font10">Regulation </span>
   <span class="font10">Requirements </span>
   <span class="font10">Rev </span>
   <span class="font10">Specialist </span>
   <span class="font10">Therefore, </span>
   <span class="font10">Transl </span>
   <span class="font10">accordance </span>
   <span class="font10">accreditation </span>
   <span class="font10">accurate </span>
   <span class="font10">among </span>
   <span class="font10">antigens </span>
   <span class="font10">aphaeretic </span>
   <span class="font10">approval </span>
   <span class="font10">article </span>
   <span class="font10">aspects </span>
   <span class="font10">based </span>
   <span class="font10">bold </span>
   <span class="font10">called </span>
   <span class="font10">cells, </span>
   <span class="font10">cells; </span>
   <span class="font10">cellular </span>
   <span class="font10">chemotherapy </span>
   <span class="font10">common </span>
   <span class="font10">complications </span>
   <span class="font10">could </span>
   <span class="font10">courier; </span>
   <span class="font10">critical </span>
   <span class="font10">diffuse </span>
   <span class="font10">distribution </span>
   <span class="font10">documented </span>
   <span class="font10">each </span>
   <span class="font10">em; </span>
   <span class="font10">events, </span>
   <span class="font10">expansion </span>
   <span class="font10">experience </span>
   <span class="font10">expression </span>
   <span class="font10">facilities </span>
   <span class="font10">field </span>
   <span class="font10">figure </span>
   <span class="font10">grade </span>
   <span class="font10">iii) </span>
   <span class="font10">implemented </span>
   <span class="font10">intended </span>
   <span class="font10">leukemia </span>
   <span class="font10">long-term </span>
   <span class="font10">manage </span>
   <span class="font10">managing </span>
   <span class="font10">members </span>
   <span class="font10">number </span>
   <span class="font10">overall </span>
   <span class="font10">perform </span>
   <span class="font10">person </span>
   <span class="font10">pharmacy, </span>
   <span class="font10">point </span>
   <span class="font10">preservation, </span>
   <span class="font10">processes </span>
   <span class="font10">procurement </span>
   <span class="font10">product, </span>
   <span class="font10">products, </span>
   <span class="font10">programs </span>
   <span class="font10">pt;} </span>
   <span class="font10">refractory </span>
   <span class="font10">responses </span>
   <span class="font10">setting </span>
   <span class="font10">severe </span>
   <span class="font10">showed </span>
   <span class="font10">side </span>
   <span class="font10">still </span>
   <span class="font10">storage, </span>
   <span class="font10">strategy </span>
   <span class="font10">therapies. </span>
   <span class="font10">therefore </span>
   <span class="font10">treated </span>
   <span class="font10">useful </span>
   <span class="font10">was </span>
   <span class="font10">â€"% </span>
   <span class="font10">â€œCAR-T </span>
  </p>
 </body>
</html>
